276 related articles for article (PubMed ID: 12756092)
1. Successful treatment of vitiligo with 0.1% tacrolimus ointment.
Travis LB; Weinberg JM; Silverberg NB
Arch Dermatol; 2003 May; 139(5):571-4; discussion 573. PubMed ID: 12756092
[No Abstract] [Full Text] [Related]
2. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
3. Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment.
Ahn BK; Kim BD; Lee SJ; Lee SH
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):532-3. PubMed ID: 15761441
[No Abstract] [Full Text] [Related]
4. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color.
Silverberg JI; Silverberg NB
J Drugs Dermatol; 2011 May; 10(5):507-10. PubMed ID: 21533297
[TBL] [Abstract][Full Text] [Related]
5. Topical tacrolimus for treatment of childhood vitiligo in Asians.
Kanwar AJ; Dogra S; Parsad D
Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
[TBL] [Abstract][Full Text] [Related]
6. Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo.
Sehgal VN
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1218-9. PubMed ID: 19192018
[No Abstract] [Full Text] [Related]
7. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
[TBL] [Abstract][Full Text] [Related]
8. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus.
Taher ZA; Lauzon G; Maguiness S; Dytoc MT
Br J Dermatol; 2009 Sep; 161(3):654-9. PubMed ID: 19438859
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
Nordal EJ; Guleng GE; Rönnevig JR
J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
[TBL] [Abstract][Full Text] [Related]
10. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
[TBL] [Abstract][Full Text] [Related]
12. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
13. Verruca vulgaris following treatment with tacrolimus ointment.
Narang T; Pahwa M; Kanwar AJ; Parsad D
Dermatology; 2006; 213(3):254-5. PubMed ID: 17033184
[No Abstract] [Full Text] [Related]
14. Topical tacrolimus for repigmentation of vitiligo.
Grimes PE; Soriano T; Dytoc MT
J Am Acad Dermatol; 2002 Nov; 47(5):789-91. PubMed ID: 12399778
[TBL] [Abstract][Full Text] [Related]
15. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
Hartmann A; Bröcker EB; Hamm H
Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
Tanghetti EA
Cutis; 2003 Feb; 71(2):158-62. PubMed ID: 12635898
[TBL] [Abstract][Full Text] [Related]
17. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
[TBL] [Abstract][Full Text] [Related]
18. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
Hartmann A; Bröcker EB; Hamm H
J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
[TBL] [Abstract][Full Text] [Related]
19. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
Majid I
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
[TBL] [Abstract][Full Text] [Related]
20. Rosacea/acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment.
Sehgal VN; Sharma S; Sardana K
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1366-8. PubMed ID: 18435734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
